• Solid Tumors3
• Mutation Specific5
• Breast5
• GI12
• GU1
• Gynecologic3
• Head & Neck0
• Hematology/ Lymphoma / BMT0
• Skin1
• Thoracic (Lung, Mesothelioma, Thymic)5
• Sarcoma1

• Protocols

• NCI10495

  OPEN TO ACCRUAL

  PH1 Study of DS-8201a in Combination with Neratinib in Solid Tumors with HER2 Alterations
  
  

• UW18121

  OPEN TO ACCRUAL

  I/II Multiple Expansion Cohort Trial of MRTX849 in Pts w/ Advanced Solid Tumors with KRAS G12C Muta